-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

650 "Post-Pulmonary Embolism Syndrome" after a First Episode of PE: Results of the E.L.O.P.E. Study

Pathophysiology of Thrombosis
Program: Oral and Poster Abstracts
Type: Oral
Session: 331. Pathophysiology of Thrombosis: Prediction of VTE and Complications
Monday, December 7, 2015: 2:45 PM
W311ABCD, Level 3 (Orange County Convention Center)

Susan R Kahn, MD, MSc1, Andrew Hirsch, MD2*, Margaret Beddaoui, MSc3*, Arash Akaberi, MSc3*, David Anderson, MD4, Philip S Wells, MD, MSc5, Marc Rodger, MD, MSc6, Susan Solymoss, MD7, Michael J. Kovacs, MD8, Lawrence Rudski, MD7*, Avi Shimony, MD9*, Carole Dennie, MD10*, Chris Rush, MD11*, William H. Geerts, MD12, Paul Hernandez, MD4*, Shawn Aaron, MD13* and John T Granton, MD14*

1Center for Clinical Epidemiology, McGill University, Jewish General Hospital, Montreal, QC, Canada
2Department of Medicine, Jewish General Hospital, Montreal, QC, Canada
3Center for Clinical Epidemiology, Lady Davis Institute, Montreal, QC, Canada
4Department of Medicine, Dalhousie University, Halifax, NS, Canada
5Department of Medicine, The University of Ottawa, Ottawa, ON, Canada
6Department of Hematology, University of Ottawa, Ottawa, ON, Canada
7Department of Medicine, McGill University, Montreal, QC, Canada
8Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada
9Department of Cardiology, Ben Gurion University, Beer Sheva, Israel
10Department of Diagnostic Imaging, University of Ottawa, Ottawa, ON, Canada
11Department of Nuclear Medicine, Jewish General Hospital, Montreal, QC, Canada
12Sunnybrook Health Sciences Centre, Department of Medicine, Toronto, ON, Canada
13Department of Medicine, University of Ottawa, Ottawa, ON, Canada
14Department of Medicine, University of Toronto, Toronto, Canada

Background:  Most pulmonary embolism (PE) research has focused on acute and short-term outcomes such as mortality and PE recurrence. Whether long-term morbidity such as exercise limitation, impaired quality of life (QOL) and persistent dyspnea occurs after PE is largely unstudied. To address this knowledge gap, we performed the ELOPE study, a prospective, observational, multicenter cohort study of long-term outcomes after acute PE (www.clinicaltrials.gov NCT01174628).

Objectives: The objectives of the ELOPE (Evaluation of Long-term Outcomes after PE) Study were: (1) to describe and quantify degree of exercise limitation, QOL impairment and persistent dyspnea at 1 year after PE; and (2) to identify predictors of poor functional status at 1 year.  

Methods: Patients ≥18 years old with a 1stepisode of acute PE diagnosed within the previous 10 days screened at 5 Canadian recruiting centers were potentially eligible to participate.  Exclusion criteria were subsegmental-only PE, preexisting severe cardiopulmonary comorbidity, previous proximal DVT, contraindication to CT pulmonary angiography (CTPA), life expectancy <1 year, unable to read questionnaire in English and French or to attend follow-up visits, and unable or unwilling to consent. 

After the Baseline (B) visit, patients attended follow-up (FU) visits at 1, 3, 6 and 12 months to measure QOL (SF-36, PEmbQoL), dyspnea (UCSD SOBQ), and 6-minute walk test (6MWT) [all FU visits]; undergo CTPA [B, 12], echocardiogram [B, 12], Q scan [6, 12], cardiopulmonary exercise testing (CPET) [1, 12] and pulmonary function tests [1, 12]; and measure biomarkers (BNP, ddimer, troponin) [B, 6].

The primary study outcome was maximal aerobic capacity defined by peak oxygen uptake (VO2) as a percent of predicted maximal VO2 (VO2max) on 1-year CPET, with <80% predicted VO2max considered abnormal, as per American Thoracic Society guidelines.

For the present analysis, we summarized demographic and clinical characteristics of study subjects, the proportion of patients with VO2max <80% predicted on 1 year CPET (primary outcome), and compared mean QOL and dyspnea scores in patients with vs. without the primary outcome. Multivariate logistic regression analyses were done to identify demographic, clinical and functional predictors of abnormal VO2max at 1 year, with adjustment for relevant confounding variables.

Results: 984 patients were screened for participation; of these, 150 were eligible and 100 (67%) consented to participate. Mean (SD) age was 50 (15) years, 57% were male, 80% were outpatients and 33% had concomitant DVT. PE was provoked in 21% and unprovoked in 79%; none were cancer-related.

At 1 year, 40/86 (46.5%) of patients had <80% predicted VO2max on CPET; these patients had worse 1-year SF-36 MCS (mental) (p=0.002) and PCS (physical) (p=0.009) scores, PEmbQoL scores (p=0.002) and SOBQ scores (p=0.003), compared to patients with >80% predicted VO2max at 1 year.

Independent baseline predictors of abnormal VO2max at 1 year included: male sex (relative risk (RR)= 3.2 [95% CI 1.3-8.1]; p=0.015), age (RR 0.98 [95% CI 0.96-0.99] per 1 year age increase; p=0.002), BMI (RR 1.1 [95% CI 1.01-1.2] per 1 kg/m2BMI increase; p=0.023), and smoker (RR 1.8 [95% CI 1.1-2.9]; p=0.023). In addition, VO2max <80% predicted at 1 month and 6MWT distance at 1 month were significantly associated with risk of abnormal VO2max at 1 year (RR 3.8 [95% CI 1.9-7.2; p<0.0005] and RR 0.82 [95% CI 0.7-0.9; p=0.001] per 30m increased walking distance, respectively). Inpatient status at enrolment, previous lung disease, unprovoked vs. provoked PE, concurrent DVT, and number of days with symptoms before PE diagnosis did not influence VO2max at 1 year.

Conclusions:  PE is a common and serious cardiovascular illness, yet clinically relevant information on characteristics and determinants of long-term outcome after PE have been lacking. Results of the ELOPE Study indicate that almost half of PE patients can be considered to have a “post-PE syndrome” characterized by exercise limitation at 1 year, which influences their QOL and degree of dyspnea. Predictors of this post-PE syndrome include male sex, younger age, higher BMI and smoking. CPET testing or 6MWT testing at 1 month may help to identify patients with a higher risk of post-PE syndrome at 1 year.

Funding: Canadian Institutes of Health Research (MOP-93627)

Disclosures: Wells: Bayer: Honoraria ; BMS/Pfizer: Research Funding .

See more of: 331. Pathophysiology of Thrombosis: Prediction of VTE and Complications
See more of: Pathophysiology of Thrombosis
See more of: Oral and Poster Abstracts
Previous Abstract | Next Abstract >>

*signifies non-member of ASH